REYON PHARMACEUTICAL CO., LTD
Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.
102460 | KO
Overview
Corporate Details
- ISIN(s):
- KR7102460003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 테헤란로 620 에이동 12층 (대치동, 미래에셋타워), 강남구
- Website:
- https://www.reyonpharm.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Reyon Pharmaceutical Co., Ltd. is an integrated pharmaceutical company focused on the research, development, and manufacturing of both chemical and biopharmaceutical products. The company's core business includes the production of Active Pharmaceutical Ingredients (APIs) and finished generic formulations, such as injections, tablets, and antibiotics. Strategically expanding into next-generation therapeutics, Reyon is actively developing advanced treatments in areas like AAV gene therapy for conditions such as wet age-related macular degeneration (wAMD) and NK cell therapy for solid cancers. A significant part of its growth strategy involves its biopharmaceutical Contract Development and Manufacturing Organization (CDMO) services, which are being scaled through strategic partnerships to support the production of complex biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 2.5 MB | ||
| 2025-08-01 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.9 MB | ||
| 2025-07-25 00:00 |
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 12.2 KB | ||
| 2025-07-09 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 92.2 KB | ||
| 2025-06-02 00:00 |
Quarterly Report
[기재정정]분기보고서 (2025.03)
|
Korean | 1.8 MB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.6 MB | ||
| 2025-04-25 00:00 |
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
|
Korean | 10.9 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 24.3 KB | ||
| 2025-03-24 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 2.1 MB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 20.0 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 629.3 KB | ||
| 2025-03-14 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
|
Korean | 14.8 KB | ||
| 2025-03-14 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 1.1 MB | ||
| 2025-03-14 00:00 |
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
|
Korean | 1.0 MB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 10.9 KB |
Automate Your Workflow. Get a real-time feed of all REYON PHARMACEUTICAL CO., LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for REYON PHARMACEUTICAL CO., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for REYON PHARMACEUTICAL CO., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
